Canton Fair revealed information: Pharmaceutical trade stabilized

In recent years, China's healthcare industry is in an important stage of full integration into the global industrial chain. The export structure of pharmaceutical trade is further optimized. The pace of internationalization of enterprises is accelerating. The new momentum of development is accumulating. In the 122nd Canton Fair Medical and Health Care Pavilion, exhibitors and buyers are interacting closely, and the international recognition and influence of Chinese enterprises are gradually increasing.

Data show that in the first three quarters of this year, China's total foreign trade in medicine reached 84.953 billion U.S. dollars, up 10.71% over the same period of 2006. Of this total, exports reached 43.678 billion U.S. dollars, up by 5.61% over the same period of last year; imports hit U.S. $ 41.275 billion, a year-on-year increase of 16.66% 59.8%. Subdivided into three major categories of commodities, exports of Chinese medicine 2.6 billion US dollars, down slightly by 0.27%; Western exports of 25.395 billion US dollars, up 8.44%; medical equipment exports 15.684 billion US dollars, an increase of 2.29%.

Chinese medicine Health products Meng Dongping, vice president of the Chamber of Commerce and Administered at the Canton Fair, told the reporter in the "Medical and Economic News": China now has quietly changed the situation of relying on low-cost raw materials and has turned to products with high added value and high-tech capabilities. She said that expanding the import of pharmaceutical products is an objective need to promote the economic development of our country and an effective means to achieve the balanced development of pharmaceutical foreign trade. From January to September, the import value of pharmaceutical products in China was 41.275 billion U.S. dollars, which is almost balanced with the export value. An increase of 11.05 percentage points higher than the export.Among them, the amount of traditional Chinese medicine and medical equipment increased at a lower price, the volume of western medicine doubled.At present, China's imports of products to high-end medical equipment, pharmaceutical equipment and Western medicine-based, complementary with the domestic industry Strong, with reasonable, can effectively improve the domestic supply, is conducive to industrial restructuring and optimization and upgrading.

Reporters visited 122 Canton Fair exhibition of medicine and health care, exhibitors enterprise Optimistic about this feedback. Compared with previous years, European and American merchants have increased - this is the epitome of pharmaceutical foreign trade in the first three quarters.

At present, China's pharmaceutical foreign trade has maintained its stability in the mainstream market and its market growth in the Belt and Road has been remarkable. In the first three quarters, China's pharmaceutical products were exported to 225 countries and regions. Asia, Europe and North America are the major export markets in China with exports of 179.25 Europe and North America are the main sources of import of pharmaceutical products in China, of which North American imports increased by 17.73% compared with the same period of last year, while European imports increased by 18.05% over the same period of last year. In addition, in the first nine months, the import and export of pharmaceuticals along the Belt and Road increased by 19.95% and 5.75% respectively, of which the import from Iran increased by 144.32% and the import from Turkey increased 94.72%. The 'One Belt One Road' practice is steadily advancing in mutually beneficial cooperation.

When interviewed by the Canton Fair booth exhibitors also found that more than standard booths occupied by the production of self-export enterprises, only a few special booth for the professional trading company.In this regard, Meng Dongping said the business differentiation shows that the professional division of labor more in line with modern Social requirements.

In fact, with the gradual liberalization of the right to operate foreign trade reforms and the continuous reform of the main body of foreign trade, various enterprises are looking for their own position and differentiated competition in accordance with the laws of the market. The travails the traditional foreign trade enterprises once faced - a large number of markets Cut off by the manufacturer, no longer passed proxy Sales, but with the passage of time, professional foreign trade companies have also found their own advantages in the integration of resources, rich categories to meet market demand, language control, market tracking, etc. has a unique advantage.Catch the market demand, the foreign trade enterprises and production Now that the traditional foreign trade enterprises have exerted their comprehensive competitive advantage in terms of channels, talents and service markets, the manufacturing enterprises pay more attention to specialized production and management and continue to develop in the adjustment of the market structure .

The Canton Fair Medical Insurance Exhibition, a total of more than half of the medical dressing and consumables (exhibitors 167, accounting for 33.6%) and medical equipment and equipment (exhibitors 114, accounting for 22.9%) manufacturers.According to reports, masks, Shoe covers and other traditional non-woven products gradually to all types of surgical package product development; suture products using imported materials needles and lines, assembled in the country, the quality of imported products do not lose the brand, the price is more competitive advantage; trading company products Line also began to upgrade high-end medical equipment.

In the past three quarters of import and export data, medical equipment steady progress, import and export growth has slowed, but in the long term is still very energetic and growth .It is worth mentioning that this year, high value-added mechanical and electrical products and equipment manufacturing products In the first three quarters, advanced medical instruments and apparatus increased by 10.8% .At the same time, a similar situation was found in the Canton Fair - products with high added value and high technical content were favored by customers.

In Meng Dongping's opinion, medical equipment is a well-established industry, its development needs long-term accumulation, is a continuous improvement process .As for the industry itself, deepening the integration of industry, universities and research institutes, is to stimulate innovation in the industry, coupled with science and technology, Medical resources to the medical equipment industry tilt, the overall level of industry development and research and development strength have been significantly improved, at present in the medical imaging, in vitro diagnosis, medical accessories, implant interventional equipment, etc., more and more domestic enterprises in the production process, the core components , The key quality standards to achieve self-breakthrough, gradually changing the high-end medical equipment monopoly imported brands.

Meng Dongping said frankly that this year's environmental inspection strictly control the status quo, the domestic environmental supervision has been tightened for some time, through government governance, advocate the direction of the development of the pharmaceutical industry to encourage enterprises through the green manufacturing, product quality competition in a virtuous circle obtained In her view, some outstanding enterprises have invested heavily in reforming the production process, reducing the emission of "three wastes" and upgrading the pollution treatment equipment, etc. "In the long run, they should be well rewarded." In contrast, Environmental management capabilities, business philosophy can not keep up the small and medium enterprises, it may be eliminated by the market, the phenomenon of low-cost competition in the future will be gradually checked.

In fact, the "strictest" environmental protection law in the history of the People's Republic of China does have an impact on the market, requiring "three wastes" discharge capacity and a particularly prominent product with strong pollution control abilities - the market appears bigger than the supply for the first half of this year Export prices showed a clear rise, from the latest published customs data, the first three quarters has risen 1.7%, showing a clear turnaround.

Of course, the business as the market will be adjusted accordingly.Over the first three quarters of the data look more optimistic, bulk product growth is very obvious, amino acids increased by 17.7%, vitamin 24.4%, analgesics also increased by 7.26% Market demand picks up, capacity supply will be further restored, raw material drug companies are expected to continue the development and maintain a steady growth.